Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Clin Oncol. Aug 10, 2014; 5(3): 382-392
Published online Aug 10, 2014. doi: 10.5306/wjco.v5.i3.382
Table 1 Diagnostic markers
MarkerStaining patternUseful for
Smooth muscle actinCytoplasmic stainingMyoepithelial differentiation
CalponinCytoplasmic stainingMyoepithelial differentiation
p63NuclearMyoepithelial differentiation
Smooth muscle myosin heavy chainCytoplasmicMyoepithelial differentiation
CD10Membranous stainingMyoepithelial differentiation
S100CytoplasmicMyoepithelial differentiation
High-molecular-weight cytokeratins (14 and 5/6)CytoplasmicTo distinguish invasive carcinoma from benign proliferations; expressed by lobular carcinomas
Cytokeratin 8Peripheral cytoplasmicDuctal carcinoma cells
Cytokeratin 8Perinuclear stainingLobular carcinoma cells
CK 7 and 20Mammary origin of a metastatic carcinoma
E-cadherinMembranous stainingUsual ductal carcinomas
Hormone receptors estrogen receptor, progesterone receptorNuclearIdentified subtypes, mammary origin
HER2 neuMembranous stainingIdentified subtypes
Gross cystic disease fluid protein 15CytoplasmicMammary origin of a metastatic carcinoma
Mammaglobin ACytoplasmicMammary origin of a metastatic carcinoma
Carcinoembryonic antigen, CEAD-14 cloneCytoplasmicEvaluation of metastatic mammary carcinoma